Concepedia

Kristopher King

KK

Statistics

Publications

7

Citations

168

H-Index

7

Active since

2013

Affiliations

Biogen (United States)(Current)

Kristopher King is an author at Biogen (United States) specializing in pharmacology, drug discovery, and pharmacy.

ORCID

Publications per year

2013–2021

7

Publications

7

Rational Design and Optimization of a Novel Class of Macrocyclic Apoptosis Signal-Regulating Kinase 1 Inhibitors

Martin Himmelbauer, Zhili Xin, J. Howard Jones et al. · Journal of Medicinal Chemistry · 2019 · 35 citations · Full text

, , +16

Discovery of Potent and Brain-Penetrant Tau Tubulin Kinase 1 (TTBK1) Inhibitors that Lower Tau Phosphorylation In Vivo

Tamara Halkina, Jaclyn L. Henderson, Edward Yin-Shiang Lin et al. · Journal of Medicinal Chemistry · 2021 · 35 citations · Full text

, , +14

Acute inhibition of the CNS-specific kinase TTBK1 significantly lowers tau phosphorylation at several disease relevant sites

Gregory M. Dillon, Jaclyn L. Henderson, Channa Bao et al. · PLoS ONE · 2020 · 25 citations · Full text

, , +17

Discovery of CNS-Penetrant Apoptosis Signal-Regulating Kinase 1 (ASK1) Inhibitors

Zhili Xin, Martin Himmelbauer, J. Howard Jones et al. · ACS Medicinal Chemistry Letters · 2020 · 24 citations · Full text

, , +17

ASPECTS: an Automation-Assisted SPE Method Development System

Ming Li, Judy Chou, Kristopher King et al. · Bioanalysis · 2013 · 17 citations

, , +15

1–5 of 7